Moleculin releases CEO corner segment on MIRACLE study progress
Go back to Moleculin releases CEO corner segment on MIRACLE study progress| METABASIS THERAPEUT (NASDAQ: MBRX) | Delayed: 2.64 -0.05 (1.86%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.69 | 52 Week High | $9.58 | |||
| Open | $2.57 | 52 Week Low | $2.34 | |||
| Day High | $2.78 | P/E | N/A | |||
| Day Low | $2.56 | EPS | $-0.34 | |||
| Volume | 361,590 | |||||

